Elon Musk says Neuralink’s Blindsight device is ready to restore sight and is just waiting on regulatory approval

Elon Musk has shared a major update on Neuralink’s plans to help people with blindness, and the latest announcement could mark a significant step forward for the company.

The billionaire entrepreneur says its Blindsight brain implant is ready from an engineering standpoint and is now waiting for regulatory approval.

The ambitious technology is designed to send visual information directly to the brain, potentially bypassing damaged eyes or optic nerves.

Even more remarkably, Musk claims it could help people who have been completely blind since birth experience sight for the first time.

Neuralink’s Blindsight could help people who have never seen

Musk announced the update on October 30, 2026, in a post on X, describing Blindsight as Neuralink’s second product.

He said the technology would enable even people who are completely blind, or who have never seen before, to experience sight.

Musk added that the device was ‘ready from an engineering standpoint’ and was ‘just waiting on regulatory approval’.

The announcement is particularly interesting because Neuralink is looking beyond helping people interact with computers and toward restoring a sense that many people have lost or never experienced.

However, it’s important to remember that Musk’s announcement is not confirmation that the device has successfully restored sight in human patients.

The technology still needs to progress through the relevant regulatory and clinical stages.

How Neuralink’s brain implant is designed to work

Blindsight is designed to create an artificial visual pathway by sending information directly to the brain, potentially bypassing damaged eyes or optic nerves.

Under normal circumstances, the retina converts light into electrical signals that travel along the optic nerve before being processed by the brain.

Neuralink’s approach aims to bypass that process by using a camera to capture images of the user’s surroundings.

It then converts those images into signals and transmits them wirelessly to an implant, which stimulates brain areas responsible for visual perception.

The idea is that the brain could interpret these signals as visual information, even when the usual pathway through the eyes is no longer working.

Neuralink has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for Blindsight.

This is intended to speed up the development and review of promising medical devices, although it is not the same as full regulatory approval.

Neuralink has already made progress with brain-computer technology

Founded in 2016, Neuralink has spent years developing brain-computer interfaces designed to connect the human brain with external technology.

The company began its first human trials in 2024, initially focusing on helping people with paralysis control computers using their thoughts.

Its first product, Telepathy, is designed to allow users to communicate with computers and other people through neural signals.

Musk has also suggested that the technology could eventually allow people to communicate faster than they can speak or type.

Blindsight represents a different direction for the company because it aims to send information into the brain rather than simply interpret signals coming out of it.

There is still plenty to prove before the technology can become a real treatment option, but if Neuralink can deliver on its ambitions, it could open up an entirely new avenue for people living with blindness.